|Adherence to protease inhibitor therapy and outcomes in patients with HIV infection|
DL Paterson, S Swindells, J Mohr, M Brester, EN Vergis, C Squier, ...
Annals of internal medicine 133 (1), 21-30, 2000
|Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy|
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ...
Jama 316 (2), 171-181, 2016
|Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.|
A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ...
Journal of acquired immune deficiency syndromes (1999) 31, S123-7, 2002
|Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.|
A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, PL De, SC Lo, ...
Journal of acquired immune deficiency syndromes (1999) 28 (5), 445-449, 2001
|Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons|
A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ...
Psychosomatics 45 (5), 394-402, 2004
|Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.|
F Starace, A Ammassari, MP Trotta, R Murri, PL De, C Izzo, A Scalzini, ...
Journal of acquired immune deficiency syndromes (1999) 31, S136-9, 2002
|Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)|
A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ...
Aids 16 (3), 369-379, 2002
|Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …|
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
|Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy|
A Antinori, A Cingolani, L Alba, A Ammassari, D Serraino, BC Ciancio, ...
Aids 15 (12), 1483-1491, 2001
|Patient-reported nonadherence to HAART is related to protease inhibitor levels.|
R Murri, A Ammassari, K Gallicano, AL De, A Cingolani, D Jacobson, ...
Journal of acquired immune deficiency syndromes (1999) 24 (2), 123-128, 2000
|Relationship between HAART adherence and adipose tissue alterations.|
A Ammassari, A Antinori, A Cozzi-Lepri, MP Trotta, G Nasti, AL Ridolfo, ...
Journal of acquired immune deficiency syndromes (1999) 31, S140-4, 2002
|Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection|
M Spina, J Gabarre, G Rossi, M Fasan, C Schiantarelli, E Nigra, M Mena, ...
Blood 100 (6), 1984-1988, 2002
|Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry …|
A Antinori, A Cingolani, P Lorenzini, ML Giancola, I Uccella, S Bossolasco, ...
Journal of neurovirology 9 (1), 47-53, 2003
|Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure|
A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ...
AIDS research and human retroviruses 18 (12), 835-838, 2002
|Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS …|
A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ...
Journal of Clinical Oncology 17 (2), 554-554, 1999
|AIDS-related focal brain lesions in the era of highly active antiretroviral therapy|
A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ...
Neurology 55 (8), 1194-1200, 2000
|Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.|
E Girardi, F Palmieri, A Cingolani, A Ammassari, N Petrosillo, L Gillini, ...
Journal of acquired immune deficiency syndromes (1999) 26 (4), 326-331, 2001
|Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy|
A Antinori, D Larussa, A Cingolani, P Lorenzini, S Bossolasco, MG Finazzi, ...
Clinical infectious diseases 39 (11), 1681-1691, 2004
|Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma|
A Cingolani, A De Luca, A Ammassari, A Antinori, L Ortona, LM Larocca, ...
JNCI: Journal of the National Cancer Institute 90 (5), 364-369, 1998
|Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis|
A De Luca, A Ammassari, P Pezzotti, P Cinque, J Gasnault, J Berenguer, ...
Aids 22 (14), 1759-1767, 2008